We hypothesized that the presence of IgG or IgA immune complexes (ICs) could prevent the detection of anti-SARS-CoV-2 antibodies in these samples, in line with the recent report that ICs are potential determinants of the cytokine storm in severe COVID-19 (38). This evidence concerns the gene CD79A and COVID-19.